Complejo Hospitalario Universitario de Pontevedra
- Address
- Lg. De Mourente-Montecelo, 36071 Pontevedra, Spain
Complejo Hospitalario Universitario de Pontevedra - Dermatology Research Center
The Complejo Hospitalario Universitario de Pontevedra is actively engaged in advanced dermatological research, with particular expertise in inflammatory skin conditions. The center participates in cutting-edge clinical trials evaluating novel therapeutic approaches and dose optimization strategies for chronic dermatological disorders.
- Atopic dermatitis treatment optimization and dose flexibility studies
- Evaluation of advanced immunomodulatory therapies for moderate to severe skin conditions
- Assessment of treatment response through validated dermatological severity indices
The research team specializes in investigating atopic dermatitis management, focusing on personalized medicine approaches including dose escalation and reduction strategies. Their work evaluates the efficacy and safety of novel treatments using standardized assessment tools such as the Eczema Area and Severity Index (EASI), contributing valuable data to optimize therapeutic outcomes for patients with chronic inflammatory skin diseases.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 567 other sites in Spain
Therapeutic Area Benchmark — Spain
Select a therapeutic area to compare against other sites in Spain.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Spain
Market Share
Country: Spain
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Complejo Hospitalario Universitario de Pontevedra
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Dose Flexibility and Efficacy of Upadacitinib in Adults with Moderate to Severe Atopic Dermatitis: A Phase 3b/4 Randomized Study | AbbVie Deutschland GmbH & Co. KG | Phase I | Not Recruiting | May 2023 | Aug 2024 |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Upadacitinib | 1 | Unknown | 2023-05-31 | 2023-05-31 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.